Cisplatin treatment significantly reduced the density of CD31+ tumour blood vessels, the distribution of VE-cadherin in endothelial cells when compared with those in the non-treated tumour, while NG2+ pericyte coverage has no difference between the two groups (Figure 1B). Here, CDH5 is linked to neoplasm.